Drug Discovery

#Drug discovery #University of Glasgow #University of Southampton

Snail venom could be key to new pain relief medicines

New and more effective forms of pain relief medication could be developed using research based off the deadly venom of poisonous sea snails.   This is according to a team of researchers from the University of Glasgow, which is setting out to learn about the unique form… Read More

#News

#Covid-19 #Drug discovery #Research

Experts evaluate the effects of ACE2-mediated Covid-19 infection 

Bachem, a Swiss technology company active in the fields of chemistry, biochemistry and pharmaceuticals, as well as the development and production of peptides and oligonucleotides, analyses the findings from scientific research about the relationship between ACE2 and SARS-CoV-2.   Covid-19 has impacted almost everyone’s lives, whether through personal… Read More

#Covid-19 #Exclusive Content #News

#Drug development #Drug innovation #Funding #Investment

CatSci secures £4.5 million funding deal for drug development 

CatSci, a partner for medicines development, has secured £4.5 million of investment to expedite the development and launch of what it calls its life-changing therapeutics.  The company develops economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics… Read More

#News

#Drug development #Drug discovery #Pharma

Target product profiles and strategies for drug development

Hettie Stroebel, Founder and CEO of Launch Excellence looks at how target product profiles can be used by life sciences companies as a strategy for more effective product development.    The global effort to develop and distribute a SARS-CoV-2 vaccine in months is a triumph for the pharmaceutical industry. It is… Read More

#News #Opinion

#AAV #Drug discovery #Drug screening #NanoTemper Technologies

NanoTemper Technologies updates AAV/drug discovery portfolio  

NanoTemper Technologies has launched a number of updates to its portfolio of instruments to help researchers working in drug discovery and adeno-associated virus (AAV) therapies.  NanoTemper Technologies has launched its Spectral Shift technology to remove the roadblocks experienced by scientists dealing with really complex molecular interactions often… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Drug discovery #Podcast

Scientific data management: What does your lab need? – podcast

This is the latest episode of the free DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW.   The articles are… Read More

#News

#Biopharmaceuticals #Biotherapeutics #Drug development

Successful discovery and development collaboration continues  

Thermo Fisher Scientific and Symphogen are continuing their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterisation of complex therapeutic proteins.   Since the collaboration began in 2018, Symphogen has adopted instruments and software to improve data quality and processes… Read More

#News

#Automation / robotics #Drug discovery #Lab automation #Lab of the future

The rise of automation in drug discovery

Automation is not just for high-throughput screening anymore. New devices and greater flexibility are transforming what’s possible throughout drug discovery and development. This article was written by Thomas Albanetti, AstraZeneca; Ryan Bernhardt, Biosero; Andrew Smith, AstraZeneca and Kevin Stewart, AstraZeneca for a 28-page DDW eBook, sponsored by Bio-Rad. Download the… Read More

#Editor's Choice #Exclusive Content #News

#AI / data analytics / healthtech / informatics #Drug development #Events #Medtech #Public health

Life Science community gathers in London for key partnering event 

For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More

#News #Trending News

#Assays #Drug discovery

Domainex supports growth with investment 

Domainex has purchased over £1 million worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The company says the equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth. … Read More

#News

#Antimicrobials #Bioconvergence #Drug development #Immunology / Virology & Vaccines #mRNA

Bioconvergence: Future trends for biomedicine

Dr. Tom Knapman, Director of Strategic Brand at SCIEX, explains how bioconvergent advances will help to drive key health trends in the coming year. As we move into 2022, we will see more and more advances in bioconvergence – biological, physical, and computing technologies inspired by nature. We expect these… Read More

#Exclusive Content #News #Opinion #Trending News #Trends & Analysis

#Biopharmaceuticals #Covid-19 #Drug discovery #Pharmaceutical #Therapeutics #Women in STEM

International Women’s Day: Female achievement in drug discovery

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women’s achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trending News

#Drug design #Drug discovery #Hotspot mapping

How hotspot mapping can accelerate early-phase drug design

In a recent paper in the Journal of Chemical Information and Modeling, authors from the Cambridge Crystallographic Data Centre (CCDC), Exscientia, and Oxford University show how an automated process leveraging “ensemble hotspot maps” can identify key structural differences that contribute to the selectivity of a compound for one protein over… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Drug research #Pharmaceutical #Zebrafish

Appointment to help bridge the gap between isolated systems

The MDI Biological Laboratory (MDIBL) has appointed James Strickland as Director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development.   Background  Strickland brings experience in pharmaceutical development to his new position, in which he will leverage… Read More

#News

#AI / data analytics / healthtech / informatics #Drug design #Drug discovery

Virtual drug design platform set to accelerate drug discovery 

The Cambridge Crystallographic Data Centre (CCDC) has entered a strategic partnership with Dassault Systèmes to advance bioscience innovation with a cloud-based virtual screening solution.  The collaboration  The collaboration integrates GOLD — CCDC’s protein-ligand docking software for drug discovery — with Dassault Systèmes’ BIOVIA therapeutics design… Read More

#News

#Biopharmaceuticals #Drug development #Drug innovation #Funding

Key take-aways from new R&D trends report 

As the global Covid-19 pandemic enters its third year, the life sciences innovation system is setting new records in the level of investment, activity, and scientific progress, according to the IQVIA Institute. In its report, Global Trends in R&D: Overview through 2021, the IQVIA assesses the trends… Read More

#News #Trends & Analysis